03/29/2024
9:40 AM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Puma Biotechnology (Subject)
| Form SC 13G | |
03/19/2024
8:01 PM | AUERBACH ALAN H (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:01 PM | NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:03 PM | Puma Biotechnology (Issuer)
Wong Alvin F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:19 AM | Camber Capital Management LP (Filed by)
Puma Biotechnology (Subject)
| Form SC 13G/A | |
02/06/2024
2:54 PM | ACORN BIOVENTURES, L.P. (Filed by)
Puma Biotechnology (Subject)
| Form SC 13G/A | |
01/18/2024
8:00 AM | Puma Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/10/2024
3:38 PM | Puma Biotechnology (Subject)
Wong Alvin F (Reporting)
| Form 144/A | |
01/10/2024
3:41 PM | Puma Biotechnology (Issuer)
Wong Alvin F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:56 PM | AUERBACH ALAN H (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
6:00 PM | Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
6:03 PM | Puma Biotechnology (Issuer)
Wong Alvin F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:42 PM | HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:49 PM | NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
8:39 PM | Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2024
8:40 PM | NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2024
8:30 PM | AUERBACH ALAN H (Reporting)
Puma Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2024
8:34 PM | HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2024
8:35 PM | Puma Biotechnology (Subject)
Wong Alvin F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
7:57 PM | MILLER MICHAEL PATRICK (Reporting)
Puma Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
3:40 PM | Puma Biotechnology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
3:19 PM | Puma Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
3:10 PM | Puma Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
9:18 AM | ACORN BIOVENTURES, L.P. (Filed by)
Puma Biotechnology (Subject)
| Form SC 13G | |
08/18/2023
3:17 PM | Puma Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
3:41 PM | Puma Biotechnology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
3:12 PM | Puma Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
6:12 PM | NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
6:16 PM | Puma Biotechnology (Issuer)
Wong Alvin F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
6:03 PM | AUERBACH ALAN H (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
6:06 PM | HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
6:08 PM | Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
6:24 PM | NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2023
6:26 PM | Puma Biotechnology (Subject)
Wong Alvin F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2023
6:12 PM | AUERBACH ALAN H (Reporting)
Puma Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2023
6:16 PM | HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2023
6:18 PM | Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
8:06 PM | Puma Biotechnology (Issuer)
Stuglik Brian M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
8:10 PM | MOYES JAY M (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
8:14 PM | Puma Biotechnology (Issuer)
WILSON TROY EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
8:01 PM | Dorval Allison (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Thousands of investors use this no cost solution | Do you? (Ad) In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve.
Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media. Simply tap here now to subscribe and start getting "Insider Financial Advantage" |
06/15/2023
8:03 PM | Puma Biotechnology (Issuer)
Senderowicz Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
7:28 PM | MILLER MICHAEL PATRICK (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
7:10 PM | Cesano Alessandra (Reporting)
Puma Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:10 PM | Puma Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
8:24 PM | Puma Biotechnology (Subject)
WILSON TROY EDWARD (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023
8:13 PM | MOYES JAY M (Reporting)
Puma Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023
8:21 PM | Puma Biotechnology (Subject)
Senderowicz Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023
8:22 PM | Puma Biotechnology (Subject)
Stuglik Brian M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023
8:09 PM | Dorval Allison (Reporting)
Puma Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023
8:11 PM | MILLER MICHAEL PATRICK (Reporting)
Puma Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2023
3:36 PM | Puma Biotechnology (Issuer)
Wong Alvin F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
5:47 PM | Puma Biotechnology (Subject)
Wong Alvin F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/04/2023
3:41 PM | Puma Biotechnology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2023
7:10 AM | Puma Biotechnology (Filer)
| Form DEF 14A | |
04/28/2023
7:12 AM | Puma Biotechnology (Filer)
| Form ARS | |
04/28/2023
7:15 AM | Puma Biotechnology (Filer)
| Form DEFA14A | |
